L Stevens1, A E Goudriaan2, A Verdejo-Garcia3, G Dom4, H Roeyers5, W Vanderplasschen1. 1. Department of Special Education,University of Ghent,Ghent,Belgium. 2. Amsterdam Institute for Addiction Research,Department of Psychiatry,Academic Medical Centre, University of Amsterdam,Amsterdam,the Netherlands. 3. School of Psychological Sciences, Monash University,Melbourne,Victoria,Australia. 4. Collaborative Antwerp Psychiatric Research Institute, University of Antwerp,Antwerp,Belgium. 5. Department of Experimental Clinical and Health Psychology,University of Ghent,Ghent,Belgium.
Abstract
BACKGROUND: Impulsivity is a hallmark characteristic of substance use disorders. Recently, studies have begun to explore whether increased impulsivity in substance-dependent individuals (SDIs) is associated with a greater propensity to relapse following treatment. Despite growing recognition of its multidimensional nature, however, most studies have treated impulsivity unilaterally. Accordingly, it remains unclear whether certain facets of impulsivity are more relevant to relapse than others. The aim of the current study was to examine the relationship between multiple facets of impulsivity and short-term relapse in SDIs. As a secondary aim, we explored the role of treatment retention in this relationship. METHOD: A personality-based impulsivity questionnaire (UPPS) and three neurocognitive tasks of impulsivity [stop-signal task (SST), delay discounting task (DDT) and Iowa gambling task (IGT)] were administered in a heterogeneous sample of 70 SDIs shortly following their entry in an in-patient detoxification programme. Mediation analyses were performed to explore whether the effects of impulsivity on relapse were mediated by treatment retention. RESULTS: Performance on two neurocognitive indices of impulsive choice (i.e. delay discounting and impulsive decision-making) significantly predicted short-term relapse. The effects of delay discounting and impulsive decision-making on relapse propensity were mediated by treatment retention. CONCLUSIONS: Neurocognitive indices of impulsivity may be more sensitive to the prediction of relapse than trait-based self-report questionnaires. Post-treatment relapse in SDIs may be reduced by targeting the processes involved in impulsive choice and by improving treatment retention in SDIs with inflated impulsivity.
BACKGROUND: Impulsivity is a hallmark characteristic of substance use disorders. Recently, studies have begun to explore whether increased impulsivity in substance-dependent individuals (SDIs) is associated with a greater propensity to relapse following treatment. Despite growing recognition of its multidimensional nature, however, most studies have treated impulsivity unilaterally. Accordingly, it remains unclear whether certain facets of impulsivity are more relevant to relapse than others. The aim of the current study was to examine the relationship between multiple facets of impulsivity and short-term relapse in SDIs. As a secondary aim, we explored the role of treatment retention in this relationship. METHOD: A personality-based impulsivity questionnaire (UPPS) and three neurocognitive tasks of impulsivity [stop-signal task (SST), delay discounting task (DDT) and Iowa gambling task (IGT)] were administered in a heterogeneous sample of 70 SDIs shortly following their entry in an in-patient detoxification programme. Mediation analyses were performed to explore whether the effects of impulsivity on relapse were mediated by treatment retention. RESULTS: Performance on two neurocognitive indices of impulsive choice (i.e. delay discounting and impulsive decision-making) significantly predicted short-term relapse. The effects of delay discounting and impulsive decision-making on relapse propensity were mediated by treatment retention. CONCLUSIONS: Neurocognitive indices of impulsivity may be more sensitive to the prediction of relapse than trait-based self-report questionnaires. Post-treatment relapse in SDIs may be reduced by targeting the processes involved in impulsive choice and by improving treatment retention in SDIs with inflated impulsivity.
Authors: Jasmine Turna; Sabrina K Syan; Benicio N Frey; Brian Rush; Mary Jean Costello; Mark Weiss; James MacKillop Journal: Alcohol Clin Exp Res Date: 2019-02-19 Impact factor: 3.455
Authors: Gustavo Gonzalez-Cuevas; Remi Martin-Fardon; Tony M Kerr; David G Stouffer; Loren H Parsons; Dana C Hammell; Stan L Banks; Audra L Stinchcomb; Friedbert Weiss Journal: Neuropsychopharmacology Date: 2018-03-22 Impact factor: 7.853
Authors: Angela J Langdon; Brett A Hathaway; Samuel Zorowitz; Cailean B W Harris; Catharine A Winstanley Journal: Psychopharmacology (Berl) Date: 2019-06-29 Impact factor: 4.530
Authors: Jonathan J K Stoltman; Eric A Woodcock; Jamey J Lister; Leslie H Lundahl; Mark K Greenwald Journal: Exp Clin Psychopharmacol Date: 2015-12 Impact factor: 3.157
Authors: Holly McCready; Milky Kohno; Michael Kolessar; Laura Dennis; Daniel Kriz; Hannah Luber; Renee Anderson; Michael Chang; Anna Sasaki; Kenneth Flora; Arthur Vandenbark; Suzanne H Mitchell; Jennifer M Loftis; William F Hoffman; Marilyn Huckans Journal: J Neurovirol Date: 2018-10-08 Impact factor: 2.643